Sciarra, A.; Santarelli, V.; Salciccia, S.; Moriconi, M.; Basile, G.; Santodirocco, L.; Carino, D.; Frisenda, M.; Di Pierro, G.; Del Giudice, F.;
et al. How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy. Cancers 2024, 16, 764.
https://doi.org/10.3390/cancers16040764
AMA Style
Sciarra A, Santarelli V, Salciccia S, Moriconi M, Basile G, Santodirocco L, Carino D, Frisenda M, Di Pierro G, Del Giudice F,
et al. How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy. Cancers. 2024; 16(4):764.
https://doi.org/10.3390/cancers16040764
Chicago/Turabian Style
Sciarra, Alessandro, Valerio Santarelli, Stefano Salciccia, Martina Moriconi, Greta Basile, Loreonzo Santodirocco, Dalila Carino, Marco Frisenda, Giovanni Di Pierro, Francesco Del Giudice,
and et al. 2024. "How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy" Cancers 16, no. 4: 764.
https://doi.org/10.3390/cancers16040764
APA Style
Sciarra, A., Santarelli, V., Salciccia, S., Moriconi, M., Basile, G., Santodirocco, L., Carino, D., Frisenda, M., Di Pierro, G., Del Giudice, F., Gentilucci, A., & Bevilacqua, G.
(2024). How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy. Cancers, 16(4), 764.
https://doi.org/10.3390/cancers16040764